Literature DB >> 27387064

Human Cytomegalovirus Immediate-Early 1 Protein Rewires Upstream STAT3 to Downstream STAT1 Signaling Switching an IL6-Type to an IFNγ-Like Response.

Thomas Harwardt1, Simone Lukas1, Marion Zenger1, Tobias Reitberger1, Daniela Danzer1, Theresa Übner1, Diane C Munday2, Michael Nevels1,2, Christina Paulus1,2.   

Abstract

The human cytomegalovirus (hCMV) major immediate-early 1 protein (IE1) is best known for activating transcription to facilitate viral replication. Here we present transcriptome data indicating that IE1 is as significant a repressor as it is an activator of host gene expression. Human cells induced to express IE1 exhibit global repression of IL6- and oncostatin M-responsive STAT3 target genes. This repression is followed by STAT1 phosphorylation and activation of STAT1 target genes normally induced by IFNγ. The observed repression and subsequent activation are both mediated through the same region (amino acids 410 to 445) in the C-terminal domain of IE1, and this region serves as a binding site for STAT3. Depletion of STAT3 phenocopies the STAT1-dependent IFNγ-like response to IE1. In contrast, depletion of the IL6 receptor (IL6ST) or the STAT kinase JAK1 prevents this response. Accordingly, treatment with IL6 leads to prolonged STAT1 instead of STAT3 activation in wild-type IE1 expressing cells, but not in cells expressing a mutant protein (IE1dl410-420) deficient for STAT3 binding. A very similar STAT1-directed response to IL6 is also present in cells infected with a wild-type or revertant hCMV, but not an IE1dl410-420 mutant virus, and this response results in restricted viral replication. We conclude that IE1 is sufficient and necessary to rewire upstream IL6-type to downstream IFNγ-like signaling, two pathways linked to opposing actions, resulting in repressed STAT3- and activated STAT1-responsive genes. These findings relate transcriptional repressor and activator functions of IE1 and suggest unexpected outcomes relevant to viral pathogenesis in response to cytokines or growth factors that signal through the IL6ST-JAK1-STAT3 axis in hCMV-infected cells. Our results also reveal that IE1, a protein considered to be a key activator of the hCMV productive cycle, has an unanticipated role in tempering viral replication.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27387064      PMCID: PMC4936752          DOI: 10.1371/journal.ppat.1005748

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  177 in total

1.  "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.

Authors:  Mirko Trilling; Vu Thuy Khanh Le; Jassin Rashidi-Alavijeh; Benjamin Katschinski; Jürgen Scheller; Stefan Rose-John; Gabriela Elena Androsiac; Stipan Jonjic; Valeria Poli; Klaus Pfeffer; Hartmut Hengel
Journal:  J Immunol       Date:  2013-12-06       Impact factor: 5.422

2.  Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitors.

Authors:  Derek Daigle; Cynthia Megyola; Ayman El-Guindy; Lyn Gradoville; David Tuck; George Miller; Sumita Bhaduri-McIntosh
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

3.  Potentiation of growth hormone-induced liver suppressors of cytokine signaling messenger ribonucleic acid by cytokines.

Authors:  A Colson; A Le Cam; D Maiter; M Edery; J P Thissen
Journal:  Endocrinology       Date:  2000-10       Impact factor: 4.736

4.  A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling.

Authors:  Christina Paulus; Steffen Krauss; Michael Nevels
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-23       Impact factor: 11.205

5.  Analysis of the functions of herpes simplex virus type 1 regulatory protein ICP0 that are critical for lytic infection and derepression of quiescent viral genomes.

Authors:  Roger D Everett; Marie-Laure Parsy; Anne Orr
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

Review 6.  STATs get their move on.

Authors:  Nancy C Reich
Journal:  JAKSTAT       Date:  2013-11-13

7.  Mutational switch of an IL-6 response to an interferon-gamma-like response.

Authors:  Ana P Costa-Pereira; Silvia Tininini; Birgit Strobl; Tonino Alonzi; Joerg F Schlaak; Hayaatun Is'harc; Ida Gesualdo; Sally J Newman; Ian M Kerr; Valeria Poli
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

8.  Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells.

Authors:  Shin-ichiro Sawa; Daisuke Kamimura; Gui-Hua Jin; Hideyuki Morikawa; Hokuto Kamon; Mika Nishihara; Katsuhiko Ishihara; Masaaki Murakami; Toshio Hirano
Journal:  J Exp Med       Date:  2006-05-22       Impact factor: 14.307

9.  Latent infection of myeloid progenitors by human cytomegalovirus protects cells from FAS-mediated apoptosis through the cellular IL-10/PEA-15 pathway.

Authors:  Emma Poole; Jonathan C H Lau; John Sinclair
Journal:  J Gen Virol       Date:  2015-05-08       Impact factor: 3.891

10.  CCAAT box-dependent activation of the TATA-less human DNA polymerase alpha promoter by the human cytomegalovirus 72-kilodalton major immediate-early protein.

Authors:  G P Hayhurst; L A Bryant; R C Caswell; S M Walker; J H Sinclair
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

View more
  24 in total

1.  Nitric Oxide Attenuates Human Cytomegalovirus Infection yet Disrupts Neural Cell Differentiation and Tissue Organization.

Authors:  Rebekah L Mokry; Benjamin S O'Brien; Jacob W Adelman; Suzette Rosas; Megan L Schumacher; Allison D Ebert; Scott S Terhune
Journal:  J Virol       Date:  2022-07-07       Impact factor: 6.549

2.  miRNA-mediated targeting of human cytomegalovirus reveals biological host and viral targets of IE2.

Authors:  Rasmus Møller; Toni M Schwarz; Vanessa M Noriega; Maryline Panis; David Sachs; Domenico Tortorella; Benjamin R tenOever
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-16       Impact factor: 11.205

3.  Human Cytomegalovirus Utilizes a Nontraditional Signal Transducer and Activator of Transcription 1 Activation Cascade via Signaling through Epidermal Growth Factor Receptor and Integrins To Efficiently Promote the Motility, Differentiation, and Polarization of Infected Monocytes.

Authors:  Donna Collins-McMillen; Emily V Stevenson; Jung Heon Kim; Byeong-Jae Lee; Stephen J Cieply; Maciej T Nogalski; Gary C Chan; Robert W Frost; Caroline R Spohn; Andrew D Yurochko
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

Review 4.  The Dynamic Interface of Viruses with STATs.

Authors:  Angela R Harrison; Gregory W Moseley
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

5.  Human Cytomegalovirus Immediate Early 1 Protein Causes Loss of SOX2 from Neural Progenitor Cells by Trapping Unphosphorylated STAT3 in the Nucleus.

Authors:  Cong-Cong Wu; Xuan Jiang; Xian-Zhang Wang; Xi-Juan Liu; Xiao-Jun Li; Bo Yang; Han-Qing Ye; Thomas Harwardt; Man Jiang; Hui-Min Xia; Wei Wang; William J Britt; Christina Paulus; Michael Nevels; Min-Hua Luo
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

6.  The aryl hydrocarbon receptor facilitates the human cytomegalovirus-mediated G1/S block to cell cycle progression.

Authors:  Pooya Naseri-Nosar; Maciej T Nogalski; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-23       Impact factor: 12.779

7.  Association of Human Cytomegalovirus with Hodgkin’s Disease and Non-Hodgkin’s lymphomas

Authors:  Hamide Mehravaran; Manoochehr Makvandi; Alireza Samarbaf Zade; Niloofar Neisi; Hadis Kiani; Hashem Radmehr; Toran Shahani; Seyedeh Zeinab Hoseini; Nastaran Ranjbari; Rahil Nahid Samiei
Journal:  Asian Pac J Cancer Prev       Date:  2017-03-01

8.  The antiviral restriction factor IFN-induced transmembrane protein 3 prevents cytokine-driven CMV pathogenesis.

Authors:  Maria A Stacey; Simon Clare; Mathew Clement; Morgan Marsden; Juneid Abdul-Karim; Leanne Kane; Katherine Harcourt; Cordelia Brandt; Ceri A Fielding; Sarah E Smith; Rachael S Wash; Silvia Gimeno Brias; Gabrielle Stack; George Notley; Emma L Cambridge; Christopher Isherwood; Anneliese O Speak; Zoë Johnson; Walter Ferlin; Simon A Jones; Paul Kellam; Ian R Humphreys
Journal:  J Clin Invest       Date:  2017-02-27       Impact factor: 14.808

9.  Lysyl Oxidase-Like 4 Fosters an Immunosuppressive Microenvironment During Hepatocarcinogenesis.

Authors:  Hor-Yue Tan; Ning Wang; Cheng Zhang; Yau-Tuen Chan; Man-Fung Yuen; Yibin Feng
Journal:  Hepatology       Date:  2021-05-21       Impact factor: 17.425

10.  Oncostatin M induces RIG-I and MDA5 expression and enhances the double-stranded RNA response in fibroblasts.

Authors:  Sabine Hergovits; Christine Mais; Claude Haan; Ana P Costa-Pereira; Heike M Hermanns
Journal:  J Cell Mol Med       Date:  2017-05-30       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.